ArticleBritish journal of cancer2023

Children with chronic myeloid leukaemia treated with front-line imatinib have a slower molecular response and comparable survival compared with adults: a multicenter experience in Taiwan.

Hsi-Che Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.